Alantra advises GPNZ on its sale to mydent

Sep 2026

Sell-side advisory

Frankfurt – Alantra has acted as exclusive financial advisor to Gesellschaft für Praxisnachfolge in der Zahnmedizin GmbH (“GPNZ”), one of Germany’s leading independent dental service organization platforms, on its sale to MYDENT zahnmedizinisches Versorgungszentrum (“mydent”).

Founded in 2018, GPNZ operates a network of 19 dental clinics, a dental laboratory and a hospital, employing approximately 380 professionals. The Group has built a strong presence in Germany, with a particular focus on mid-sized cities and affluent suburban areas.

mydent is an independent, dentist-led dental group founded in 2018 by Dr. Kutlutürk and Dr. Özcan. The group currently operates 12 locations across North Rhine-Westphalia and Hesse and offers a broad range of modern dental services, including general dentistry and preventive care, implantology, oral surgery, endodontics, orthodontics and aesthetic dentistry.

The combination brings together two established dental groups with complementary regional footprints, creating a network of around 30 locations across Germany. Together, GPNZ and mydent will have greater scale to support the continued development of their practices and services and drive further growth in the years ahead.

Dr. Raphael Clemm, CEO of GPNZ, said: “The combination with mydent marks an important next step for GPNZ and creates a strong foundation for the continued development and growth of the group. We thank Alantra for its deep sector expertise and dedicated support throughout the transaction.”

Christopher Jobst, Managing Director and Head of Healthcare Germany at Alantra, said: “This transaction brings together two complementary dental networks and creates meaningful scale in a still-fragmented market. With succession, recruitment and investment needs increasing, larger platforms are well positioned to support practitioners and drive further consolidation.”

This transaction adds to Alantra’s strong track record in Healthcare in Germany and across the DACH region. Recent transactions include advising FLOTTE on the sale of sanotact to Avista Healthcare Partners and Damier, the shareholders of MEDWING on the sale of InSitu to Vivecti Group and on the sale of MEDWING International Recruiting to Klett Kita & Schule, Luxempart on its partnership with VALEARA, KIRKBI on its investment in AMBOSS, and Affidea on its acquisition of Uroviva Group.